Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

BELBUCA 150 MCG FILM

buprenorphine hydrochloride
$7.5560per EA
DEA Schedule CIII

Strength

150 ug/1

Manufacturer

BioDelivery Sciences International Inc

NDC

59385002260

Classification

Brand

Dosage Form

FILM, SOLUBLE

Route

BUCCAL

Last Updated

1/1/2026

Active Ingredients

BUPRENORPHINE HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA207932

On Market Since

10/1/2017

Pharmacological Classes

Partial Opioid Agonist
Partial Opioid Agonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+5.0%

1Y

+4.8%

3Y

+16.7%

5Y

+28.9%

All

+71.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

SUBOXONE 2 MG-0.5 MG SL FILM
Brand
12496120203•Indivior Inc.
$4.7853
per EA
ZUBSOLV 0.7-0.18 MG TABLET SL
Brand
54123090730•Orexo US, Inc.
$5.2599
per EA
ZUBSOLV 1.4-0.36 MG TABLET SL
Brand
54123091430•Orexo US, Inc.
$5.2767
per EA
SUBOXONE 4 MG-1 MG SL FILM
Brand
12496120403•Indivior Inc.
$8.5848
per EA
SUBOXONE 8 MG-2 MG SL FILM
Brand
12496120803•Indivior Inc.
$8.5983
per EA
ZUBSOLV 2.9-0.71 MG TABLET SL
Brand
54123092930•Orexo US, Inc.
$10.5396
per EA
ZUBSOLV 5.7-1.4 MG TABLET SL
Brand
54123095730•Orexo US, Inc.
$10.5559
per EA
ZUBSOLV 8.6-2.1 MG TABLET SL
Brand
54123098630•Orexo US, Inc.
$15.8386
per EA
SUBOXONE 12 MG-3 MG SL FILM
Brand
12496121203•Indivior Inc.
$17.1700
per EA
ZUBSOLV 11.4-2.9 MG TABLET SL
Brand
54123011430•Orexo US, Inc.
$21.1353
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy